
À propos de ce podcast
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
100 épisodes · Business
The Top Line
Dernier épisodeInside Teva's Weltruza launch and Novo's GLP-1 strategy
À propos de ce podcast
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
Épisodes récents
- The Next Chapter for AI in Clinical Trials [Sponsored]15 oct. · 33 min
- How AI could improve clinical trial decision-making (Sponsored)12 oct. · 23 min
- How we picked the Fierce 159 oct. · 23 min
- Locking in on pharma’s consumerization trend2 oct. · 19 min
- Fierce Pharma Week: A look at the biggest trends, campaigns and conversations25 sept. · 25 min
- Inside the growing world of biopharma prediction markets18 sept. · 24 min
- Clinical trials reach a new automation inflection point (Sponsored)14 sept. · 17 min
- The future of RAS inhibitors11 sept. · 29 min
- The people who stayed with the problem4 sept. · 25 min
- Why Diagnostic-Driven Therapies Still Miss Eligible Patients (Sponsored)2 sept. · 13 min